Mechanisms of sex differences in TNFR2-mediated cardioprotection

TNFR1/TNFR2 signaling may mediate different cellular and molecular responses (injury versus protection) and the balance may be affected by sex hormones. Previous studies have shown that females have improved myocardial functional recovery, TNFR1 signaling resistance, and increased SOCS3 expression a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2008-09, Vol.118 (14 Suppl), p.S38-S45
Hauptverfasser: Wang, Meijing, Crisostomo, Paul R, Markel, Troy A, Wang, Yue, Meldrum, Daniel R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S45
container_issue 14 Suppl
container_start_page S38
container_title Circulation (New York, N.Y.)
container_volume 118
creator Wang, Meijing
Crisostomo, Paul R
Markel, Troy A
Wang, Yue
Meldrum, Daniel R
description TNFR1/TNFR2 signaling may mediate different cellular and molecular responses (injury versus protection) and the balance may be affected by sex hormones. Previous studies have shown that females have improved myocardial functional recovery, TNFR1 signaling resistance, and increased SOCS3 expression after acute ischemia/reperfusion when compared with males. However, it is unknown whether the TNFR2 pathway protects the myocardium from ischemia/reperfusion injury, and if so, whether sex differences exist in TNFR2-mediated cardioprotection. Therefore, we hypothesized that (1) TNFR2 mediates myocardial protection from ischemia/reperfusion through STAT3, SOCS3, and vascular endothelial growth factor in both sexes; and (2) TNFR2 elicits greater protective signaling in females compared with males. Isolated male and female mouse hearts from TNFR2 knockout, TNFR1/2 knockout, and wild-type (C57BL/6J or B6129SF2/J; n=5 to 6/group) were subjected to 20 minutes ischemia followed by 60 minutes reperfusion. TNFR2 deficiency decreased postischemic myocardial recovery in both sexes but had a greater effect on females. The deleterious effects of TNFR2 ablation were associated with a decrease in mRNA and protein levels of SOCS3, STAT3, and vascular endothelial growth factor as well as an increase in myocardial interleukin-1-beta production in female hearts. However, a significant increase in JNK activation and interleukin-1-beta protein levels was noted in male TNFR2KO hearts after ischemia/reperfusion. Additionally, TNFR1/2 knockout decreased myocardial function in female hearts but not males. This observation was associated with a decrease in mRNA levels of SOCS3, STAT3, and vascular endothelial growth factor and an increase in myocardial p38 mitogen-activated protein kinase activation in females. Sex differences in the mechanisms of TNFR2-mediated cardioprotection occur by increasing STAT3, SOCS3, and vascular endothelial growth factor in females and by decreasing JNK in males.
doi_str_mv 10.1161/circulationaha.107.756890
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2655136</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69605333</sourcerecordid><originalsourceid>FETCH-LOGICAL-c537t-67c833af5c76173a4e27674f59a77a8526c4aa33f1d00234c9812832e1717aa33</originalsourceid><addsrcrecordid>eNpVUFtPwjAUboxGEP0LZr74NuxlbbcXIyEiJAgJgefm2HVSs63YDqP_3i0QL08n53znu-RD6IbgISGC3Gnr9b6ExroatjAkWA4lF2mGT1CfcJrECWfZKepjjLNYMkp76CKEt3YVTPJz1CNpShMpZB89PBu9hdqGKkSuiIL5jHJbFMabWpsQ2TpaLyYrGlcmt9CYPNLgc-t23jVGdwEu0VkBZTBXxzlAm8njejyN58un2Xg0jzVnsomF1CljUHAtBZEMEkNb_6TgGUgJKadCJwCMFSTHmLJEZymhKaOGSCI7YIDuD7q7_UsbRpu68VCqnbcV-C_lwKr_SG236tV9KCo4J0y0ArdHAe_e9yY0qrJBm7KE2rh9UCITmDPWOWWHR-1dCN4UPyYEq65_NZ6txpv5aD1bLkbTUXuW6tB_y73-m_KXeSycfQPpV4S5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69605333</pqid></control><display><type>article</type><title>Mechanisms of sex differences in TNFR2-mediated cardioprotection</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Ovid Autoload</source><creator>Wang, Meijing ; Crisostomo, Paul R ; Markel, Troy A ; Wang, Yue ; Meldrum, Daniel R</creator><creatorcontrib>Wang, Meijing ; Crisostomo, Paul R ; Markel, Troy A ; Wang, Yue ; Meldrum, Daniel R</creatorcontrib><description>TNFR1/TNFR2 signaling may mediate different cellular and molecular responses (injury versus protection) and the balance may be affected by sex hormones. Previous studies have shown that females have improved myocardial functional recovery, TNFR1 signaling resistance, and increased SOCS3 expression after acute ischemia/reperfusion when compared with males. However, it is unknown whether the TNFR2 pathway protects the myocardium from ischemia/reperfusion injury, and if so, whether sex differences exist in TNFR2-mediated cardioprotection. Therefore, we hypothesized that (1) TNFR2 mediates myocardial protection from ischemia/reperfusion through STAT3, SOCS3, and vascular endothelial growth factor in both sexes; and (2) TNFR2 elicits greater protective signaling in females compared with males. Isolated male and female mouse hearts from TNFR2 knockout, TNFR1/2 knockout, and wild-type (C57BL/6J or B6129SF2/J; n=5 to 6/group) were subjected to 20 minutes ischemia followed by 60 minutes reperfusion. TNFR2 deficiency decreased postischemic myocardial recovery in both sexes but had a greater effect on females. The deleterious effects of TNFR2 ablation were associated with a decrease in mRNA and protein levels of SOCS3, STAT3, and vascular endothelial growth factor as well as an increase in myocardial interleukin-1-beta production in female hearts. However, a significant increase in JNK activation and interleukin-1-beta protein levels was noted in male TNFR2KO hearts after ischemia/reperfusion. Additionally, TNFR1/2 knockout decreased myocardial function in female hearts but not males. This observation was associated with a decrease in mRNA levels of SOCS3, STAT3, and vascular endothelial growth factor and an increase in myocardial p38 mitogen-activated protein kinase activation in females. Sex differences in the mechanisms of TNFR2-mediated cardioprotection occur by increasing STAT3, SOCS3, and vascular endothelial growth factor in females and by decreasing JNK in males.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/circulationaha.107.756890</identifier><identifier>PMID: 18824767</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Apoptosis ; Down-Regulation ; Enzyme Activation ; Female ; Heart - physiopathology ; In Vitro Techniques ; Interleukin-1beta - biosynthesis ; Male ; Mice ; Mice, Knockout ; Mitogen-Activated Protein Kinases - metabolism ; Myocardial Reperfusion Injury - metabolism ; Myocardial Reperfusion Injury - physiopathology ; Myocardial Reperfusion Injury - prevention &amp; control ; Myocardium - metabolism ; Receptors, Tumor Necrosis Factor, Type I - deficiency ; Receptors, Tumor Necrosis Factor, Type I - metabolism ; Receptors, Tumor Necrosis Factor, Type II - deficiency ; Receptors, Tumor Necrosis Factor, Type II - metabolism ; Recovery of Function ; RNA, Messenger - metabolism ; Sex Characteristics ; Signal Transduction ; STAT3 Transcription Factor - genetics ; STAT3 Transcription Factor - metabolism ; Suppressor of Cytokine Signaling Proteins - genetics ; Suppressor of Cytokine Signaling Proteins - metabolism ; Up-Regulation ; Vascular Endothelial Growth Factor A - genetics ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>Circulation (New York, N.Y.), 2008-09, Vol.118 (14 Suppl), p.S38-S45</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c537t-67c833af5c76173a4e27674f59a77a8526c4aa33f1d00234c9812832e1717aa33</citedby><cites>FETCH-LOGICAL-c537t-67c833af5c76173a4e27674f59a77a8526c4aa33f1d00234c9812832e1717aa33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3687,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18824767$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Meijing</creatorcontrib><creatorcontrib>Crisostomo, Paul R</creatorcontrib><creatorcontrib>Markel, Troy A</creatorcontrib><creatorcontrib>Wang, Yue</creatorcontrib><creatorcontrib>Meldrum, Daniel R</creatorcontrib><title>Mechanisms of sex differences in TNFR2-mediated cardioprotection</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>TNFR1/TNFR2 signaling may mediate different cellular and molecular responses (injury versus protection) and the balance may be affected by sex hormones. Previous studies have shown that females have improved myocardial functional recovery, TNFR1 signaling resistance, and increased SOCS3 expression after acute ischemia/reperfusion when compared with males. However, it is unknown whether the TNFR2 pathway protects the myocardium from ischemia/reperfusion injury, and if so, whether sex differences exist in TNFR2-mediated cardioprotection. Therefore, we hypothesized that (1) TNFR2 mediates myocardial protection from ischemia/reperfusion through STAT3, SOCS3, and vascular endothelial growth factor in both sexes; and (2) TNFR2 elicits greater protective signaling in females compared with males. Isolated male and female mouse hearts from TNFR2 knockout, TNFR1/2 knockout, and wild-type (C57BL/6J or B6129SF2/J; n=5 to 6/group) were subjected to 20 minutes ischemia followed by 60 minutes reperfusion. TNFR2 deficiency decreased postischemic myocardial recovery in both sexes but had a greater effect on females. The deleterious effects of TNFR2 ablation were associated with a decrease in mRNA and protein levels of SOCS3, STAT3, and vascular endothelial growth factor as well as an increase in myocardial interleukin-1-beta production in female hearts. However, a significant increase in JNK activation and interleukin-1-beta protein levels was noted in male TNFR2KO hearts after ischemia/reperfusion. Additionally, TNFR1/2 knockout decreased myocardial function in female hearts but not males. This observation was associated with a decrease in mRNA levels of SOCS3, STAT3, and vascular endothelial growth factor and an increase in myocardial p38 mitogen-activated protein kinase activation in females. Sex differences in the mechanisms of TNFR2-mediated cardioprotection occur by increasing STAT3, SOCS3, and vascular endothelial growth factor in females and by decreasing JNK in males.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Down-Regulation</subject><subject>Enzyme Activation</subject><subject>Female</subject><subject>Heart - physiopathology</subject><subject>In Vitro Techniques</subject><subject>Interleukin-1beta - biosynthesis</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Mitogen-Activated Protein Kinases - metabolism</subject><subject>Myocardial Reperfusion Injury - metabolism</subject><subject>Myocardial Reperfusion Injury - physiopathology</subject><subject>Myocardial Reperfusion Injury - prevention &amp; control</subject><subject>Myocardium - metabolism</subject><subject>Receptors, Tumor Necrosis Factor, Type I - deficiency</subject><subject>Receptors, Tumor Necrosis Factor, Type I - metabolism</subject><subject>Receptors, Tumor Necrosis Factor, Type II - deficiency</subject><subject>Receptors, Tumor Necrosis Factor, Type II - metabolism</subject><subject>Recovery of Function</subject><subject>RNA, Messenger - metabolism</subject><subject>Sex Characteristics</subject><subject>Signal Transduction</subject><subject>STAT3 Transcription Factor - genetics</subject><subject>STAT3 Transcription Factor - metabolism</subject><subject>Suppressor of Cytokine Signaling Proteins - genetics</subject><subject>Suppressor of Cytokine Signaling Proteins - metabolism</subject><subject>Up-Regulation</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUFtPwjAUboxGEP0LZr74NuxlbbcXIyEiJAgJgefm2HVSs63YDqP_3i0QL08n53znu-RD6IbgISGC3Gnr9b6ExroatjAkWA4lF2mGT1CfcJrECWfZKepjjLNYMkp76CKEt3YVTPJz1CNpShMpZB89PBu9hdqGKkSuiIL5jHJbFMabWpsQ2TpaLyYrGlcmt9CYPNLgc-t23jVGdwEu0VkBZTBXxzlAm8njejyN58un2Xg0jzVnsomF1CljUHAtBZEMEkNb_6TgGUgJKadCJwCMFSTHmLJEZymhKaOGSCI7YIDuD7q7_UsbRpu68VCqnbcV-C_lwKr_SG236tV9KCo4J0y0ArdHAe_e9yY0qrJBm7KE2rh9UCITmDPWOWWHR-1dCN4UPyYEq65_NZ6txpv5aD1bLkbTUXuW6tB_y73-m_KXeSycfQPpV4S5</recordid><startdate>20080930</startdate><enddate>20080930</enddate><creator>Wang, Meijing</creator><creator>Crisostomo, Paul R</creator><creator>Markel, Troy A</creator><creator>Wang, Yue</creator><creator>Meldrum, Daniel R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080930</creationdate><title>Mechanisms of sex differences in TNFR2-mediated cardioprotection</title><author>Wang, Meijing ; Crisostomo, Paul R ; Markel, Troy A ; Wang, Yue ; Meldrum, Daniel R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c537t-67c833af5c76173a4e27674f59a77a8526c4aa33f1d00234c9812832e1717aa33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Down-Regulation</topic><topic>Enzyme Activation</topic><topic>Female</topic><topic>Heart - physiopathology</topic><topic>In Vitro Techniques</topic><topic>Interleukin-1beta - biosynthesis</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Mitogen-Activated Protein Kinases - metabolism</topic><topic>Myocardial Reperfusion Injury - metabolism</topic><topic>Myocardial Reperfusion Injury - physiopathology</topic><topic>Myocardial Reperfusion Injury - prevention &amp; control</topic><topic>Myocardium - metabolism</topic><topic>Receptors, Tumor Necrosis Factor, Type I - deficiency</topic><topic>Receptors, Tumor Necrosis Factor, Type I - metabolism</topic><topic>Receptors, Tumor Necrosis Factor, Type II - deficiency</topic><topic>Receptors, Tumor Necrosis Factor, Type II - metabolism</topic><topic>Recovery of Function</topic><topic>RNA, Messenger - metabolism</topic><topic>Sex Characteristics</topic><topic>Signal Transduction</topic><topic>STAT3 Transcription Factor - genetics</topic><topic>STAT3 Transcription Factor - metabolism</topic><topic>Suppressor of Cytokine Signaling Proteins - genetics</topic><topic>Suppressor of Cytokine Signaling Proteins - metabolism</topic><topic>Up-Regulation</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Meijing</creatorcontrib><creatorcontrib>Crisostomo, Paul R</creatorcontrib><creatorcontrib>Markel, Troy A</creatorcontrib><creatorcontrib>Wang, Yue</creatorcontrib><creatorcontrib>Meldrum, Daniel R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Meijing</au><au>Crisostomo, Paul R</au><au>Markel, Troy A</au><au>Wang, Yue</au><au>Meldrum, Daniel R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanisms of sex differences in TNFR2-mediated cardioprotection</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2008-09-30</date><risdate>2008</risdate><volume>118</volume><issue>14 Suppl</issue><spage>S38</spage><epage>S45</epage><pages>S38-S45</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><abstract>TNFR1/TNFR2 signaling may mediate different cellular and molecular responses (injury versus protection) and the balance may be affected by sex hormones. Previous studies have shown that females have improved myocardial functional recovery, TNFR1 signaling resistance, and increased SOCS3 expression after acute ischemia/reperfusion when compared with males. However, it is unknown whether the TNFR2 pathway protects the myocardium from ischemia/reperfusion injury, and if so, whether sex differences exist in TNFR2-mediated cardioprotection. Therefore, we hypothesized that (1) TNFR2 mediates myocardial protection from ischemia/reperfusion through STAT3, SOCS3, and vascular endothelial growth factor in both sexes; and (2) TNFR2 elicits greater protective signaling in females compared with males. Isolated male and female mouse hearts from TNFR2 knockout, TNFR1/2 knockout, and wild-type (C57BL/6J or B6129SF2/J; n=5 to 6/group) were subjected to 20 minutes ischemia followed by 60 minutes reperfusion. TNFR2 deficiency decreased postischemic myocardial recovery in both sexes but had a greater effect on females. The deleterious effects of TNFR2 ablation were associated with a decrease in mRNA and protein levels of SOCS3, STAT3, and vascular endothelial growth factor as well as an increase in myocardial interleukin-1-beta production in female hearts. However, a significant increase in JNK activation and interleukin-1-beta protein levels was noted in male TNFR2KO hearts after ischemia/reperfusion. Additionally, TNFR1/2 knockout decreased myocardial function in female hearts but not males. This observation was associated with a decrease in mRNA levels of SOCS3, STAT3, and vascular endothelial growth factor and an increase in myocardial p38 mitogen-activated protein kinase activation in females. Sex differences in the mechanisms of TNFR2-mediated cardioprotection occur by increasing STAT3, SOCS3, and vascular endothelial growth factor in females and by decreasing JNK in males.</abstract><cop>United States</cop><pmid>18824767</pmid><doi>10.1161/circulationaha.107.756890</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2008-09, Vol.118 (14 Suppl), p.S38-S45
issn 0009-7322
1524-4539
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2655136
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Ovid Autoload
subjects Animals
Apoptosis
Down-Regulation
Enzyme Activation
Female
Heart - physiopathology
In Vitro Techniques
Interleukin-1beta - biosynthesis
Male
Mice
Mice, Knockout
Mitogen-Activated Protein Kinases - metabolism
Myocardial Reperfusion Injury - metabolism
Myocardial Reperfusion Injury - physiopathology
Myocardial Reperfusion Injury - prevention & control
Myocardium - metabolism
Receptors, Tumor Necrosis Factor, Type I - deficiency
Receptors, Tumor Necrosis Factor, Type I - metabolism
Receptors, Tumor Necrosis Factor, Type II - deficiency
Receptors, Tumor Necrosis Factor, Type II - metabolism
Recovery of Function
RNA, Messenger - metabolism
Sex Characteristics
Signal Transduction
STAT3 Transcription Factor - genetics
STAT3 Transcription Factor - metabolism
Suppressor of Cytokine Signaling Proteins - genetics
Suppressor of Cytokine Signaling Proteins - metabolism
Up-Regulation
Vascular Endothelial Growth Factor A - genetics
Vascular Endothelial Growth Factor A - metabolism
title Mechanisms of sex differences in TNFR2-mediated cardioprotection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T01%3A13%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanisms%20of%20sex%20differences%20in%20TNFR2-mediated%20cardioprotection&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Wang,%20Meijing&rft.date=2008-09-30&rft.volume=118&rft.issue=14%20Suppl&rft.spage=S38&rft.epage=S45&rft.pages=S38-S45&rft.issn=0009-7322&rft.eissn=1524-4539&rft_id=info:doi/10.1161/circulationaha.107.756890&rft_dat=%3Cproquest_pubme%3E69605333%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69605333&rft_id=info:pmid/18824767&rfr_iscdi=true